C12N 5/12
Fused cells
Official title: Fused cells, e.g. hybridomas
C12N5/12 (Fused cells) appears on 765 US grants and 905 published applications in this corpus.
Search patents in C12N- Granted patents
- 765
- Published applications
- 905
- Assignees
- 591
- Inventors
- 2,038
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 6 | 0 |
| 1986 | 7 | 0 |
| 1987 | 14 | 0 |
| 1988 | 8 | 0 |
| 1989 | 9 | 0 |
| 1990 | 16 | 0 |
| 1991 | 8 | 0 |
| 1992 | 17 | 0 |
| 1993 | 11 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 15 | 0 |
| 1997 | 12 | 0 |
| 1998 | 13 | 0 |
| 1999 | 12 | 0 |
| 2000 | 5 | 0 |
| 2001 | 15 | 4 |
| 2002 | 6 | 21 |
| 2003 | 9 | 21 |
| 2004 | 2 | 18 |
| 2005 | 3 | 20 |
| 2006 | 10 | 20 |
| 2007 | 6 | 14 |
| 2008 | 6 | 11 |
| 2009 | 12 | 23 |
| 2010 | 5 | 25 |
| 2011 | 1 | 27 |
| 2012 | 11 | 22 |
| 2013 | 14 | 28 |
| 2014 | 29 | 37 |
| 2015 | 40 | 47 |
| 2016 | 40 | 56 |
| 2017 | 55 | 54 |
| 2018 | 37 | 66 |
| 2019 | 40 | 87 |
| 2020 | 50 | 63 |
| 2021 | 38 | 50 |
| 2022 | 38 | 57 |
| 2023 | 34 | 40 |
| 2024 | 37 | 46 |
| 2025 | 37 | 30 |
| 2026 | 17 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cell lines for high level production of protein selected for rapid proliferation1 Sep 2026US 12,723,244 B2CHO Plus, Inc.
- Methods and compositions for inducible extracellular membrane capture of monoclonal immunoglobulins secreted by hybridomas25 Aug 2026US 12,715,935 B2Lankenau Institute for Medical Research
- Method for differentiating pluripotent stem cells into desired cell type25 Aug 2026US 12,716,053 B2Keio University
- Modulating TLR/NF-KB and P53 signaling pathways to enhance interspecies chimerism between evolutionaryily distant species14 Jul 2026US 12,680,084 B2Board of Regents, The University of Texas System
- Monoclonal antibody against amyloid beta, and method for measuring amyloid beta-related peptide using said antibody9 Jun 2026US 12,650,435 B2Shimadzu Corporation
- Universal donor cells27 Aug 2026US 2026/0248859 A1Crispr Therapeutics AG
- Antibodies with selectivity for the 4ig isoform of b7-h3 and methods of use thereof6 Aug 2026US 2026/0224701 A1Board of Regents, The University of Texas System
- Method for measuring pulmonary surfactant protein d, measurement kit, monoclonal antibody, and cell6 Aug 2026US 2026/0227394 A1Sekisui Medical Co., Ltd.
- Antibody compositions targeting non-phosphorylated alpha-synuclein aggregates23 Jul 2026US 2026/0209322 A1Hamad Bin Khalifa University
- Antibody for binding to interleukin 4 receptor23 Jul 2026US 2026/0209338 A1Suzhou Connect Biopharmaceuticals, Ltd.
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998
- Transgenic non-human animals for producing heterologous antibodies679US 5,814,318 AGenPharm International, Inc. · 1998